IBDEI0NT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10595,1,4,0)
 ;;=4^D31.31
 ;;^UTILITY(U,$J,358.3,10595,2)
 ;;=^5002121
 ;;^UTILITY(U,$J,358.3,10596,0)
 ;;=D31.32^^74^685^2
 ;;^UTILITY(U,$J,358.3,10596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10596,1,3,0)
 ;;=3^Benign Neop/Nevus Choroid,Left Eye
 ;;^UTILITY(U,$J,358.3,10596,1,4,0)
 ;;=4^D31.32
 ;;^UTILITY(U,$J,358.3,10596,2)
 ;;=^5002122
 ;;^UTILITY(U,$J,358.3,10597,0)
 ;;=C69.31^^74^685^3
 ;;^UTILITY(U,$J,358.3,10597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10597,1,3,0)
 ;;=3^Malig Neop/Melanoma Choroid,Right Eye
 ;;^UTILITY(U,$J,358.3,10597,1,4,0)
 ;;=4^C69.31
 ;;^UTILITY(U,$J,358.3,10597,2)
 ;;=^5001276
 ;;^UTILITY(U,$J,358.3,10598,0)
 ;;=C69.32^^74^685^4
 ;;^UTILITY(U,$J,358.3,10598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10598,1,3,0)
 ;;=3^Malig Neop/Melanoma Choroid,Left Eye
 ;;^UTILITY(U,$J,358.3,10598,1,4,0)
 ;;=4^C69.32
 ;;^UTILITY(U,$J,358.3,10598,2)
 ;;=^5001277
 ;;^UTILITY(U,$J,358.3,10599,0)
 ;;=B25.9^^74^685^11
 ;;^UTILITY(U,$J,358.3,10599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10599,1,3,0)
 ;;=3^Cytomegaloviral Disease,Unspec
 ;;^UTILITY(U,$J,358.3,10599,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,10599,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,10600,0)
 ;;=B39.9^^74^685^12
 ;;^UTILITY(U,$J,358.3,10600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10600,1,3,0)
 ;;=3^Histoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,10600,1,4,0)
 ;;=4^B39.9
 ;;^UTILITY(U,$J,358.3,10600,2)
 ;;=^5000638
 ;;^UTILITY(U,$J,358.3,10601,0)
 ;;=B58.01^^74^685^13
 ;;^UTILITY(U,$J,358.3,10601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10601,1,3,0)
 ;;=3^Toxoplasma Chorioretinitis
 ;;^UTILITY(U,$J,358.3,10601,1,4,0)
 ;;=4^B58.01
 ;;^UTILITY(U,$J,358.3,10601,2)
 ;;=^5000724
 ;;^UTILITY(U,$J,358.3,10602,0)
 ;;=H30.91^^74^685^14
 ;;^UTILITY(U,$J,358.3,10602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10602,1,3,0)
 ;;=3^Chorioretinal Inflammation,Right Eye
 ;;^UTILITY(U,$J,358.3,10602,1,4,0)
 ;;=4^H30.91
 ;;^UTILITY(U,$J,358.3,10602,2)
 ;;=^5133481
 ;;^UTILITY(U,$J,358.3,10603,0)
 ;;=H30.92^^74^685^15
 ;;^UTILITY(U,$J,358.3,10603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10603,1,3,0)
 ;;=3^Chorioretinal Inflammation,Left Eye
 ;;^UTILITY(U,$J,358.3,10603,1,4,0)
 ;;=4^H30.92
 ;;^UTILITY(U,$J,358.3,10603,2)
 ;;=^5133482
 ;;^UTILITY(U,$J,358.3,10604,0)
 ;;=H30.93^^74^685^16
 ;;^UTILITY(U,$J,358.3,10604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10604,1,3,0)
 ;;=3^Chorioretinal Inflammation,Bilateral
 ;;^UTILITY(U,$J,358.3,10604,1,4,0)
 ;;=4^H30.93
 ;;^UTILITY(U,$J,358.3,10604,2)
 ;;=^5005435
 ;;^UTILITY(U,$J,358.3,10605,0)
 ;;=H32.^^74^685^17
 ;;^UTILITY(U,$J,358.3,10605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10605,1,3,0)
 ;;=3^Chorioretinal Disorders,Secondary,Unspec
 ;;^UTILITY(U,$J,358.3,10605,1,4,0)
 ;;=4^H32.
 ;;^UTILITY(U,$J,358.3,10605,2)
 ;;=^5005489
 ;;^UTILITY(U,$J,358.3,10606,0)
 ;;=H31.001^^74^685^18
 ;;^UTILITY(U,$J,358.3,10606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10606,1,3,0)
 ;;=3^Chorioretinal Scars,Right Eye
 ;;^UTILITY(U,$J,358.3,10606,1,4,0)
 ;;=4^H31.001
 ;;^UTILITY(U,$J,358.3,10606,2)
 ;;=^5005436
 ;;^UTILITY(U,$J,358.3,10607,0)
 ;;=H31.002^^74^685^19
 ;;^UTILITY(U,$J,358.3,10607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10607,1,3,0)
 ;;=3^Chorioretinal Scars,Left Eye
 ;;^UTILITY(U,$J,358.3,10607,1,4,0)
 ;;=4^H31.002
 ;;^UTILITY(U,$J,358.3,10607,2)
 ;;=^5005437
